Biofeedback treatment of Raynaud's disease

Professional Psychology: Research and Practice

Volumn 27, Issue 6, 1996, Pages 548-553

  Sedlacek, Keith ^b   Taub, Edward ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Stress Regulation Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030523992     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.27.6.548     Document Type: Article

References (46)

1. Adee, A. C. (1993). Managing Raynaud's phenomenon: A practical approach. American Family Physicians, 47, 823-829.
2. Allen, E. V., & Brown, G. W. (1932). Raynaud's disease: A critical review of the minimal requisite for diagnosis. American Journal of Medical Science, 183, 187-200.
3. Association for Applied Psychophysiology and Biofeedback (AAPB). 10200 West 44th Avenue, #304, Wheat Ridge, Colorado 80033.
4. Basmajian, J. V. (Ed.). (1989). Biofeedback: Principals and practice for clinicians (3rd ed.). Baltimore: Williams & Wilkins.
5. Blanchard, E. B., Jaccard, J., Andrasik, F., Guarnieri, P., & Jurish, S. E., (1985). Reduction in headache patients' medical expenses associated with biofeedback and relaxation treatments. Biofeedback and Self-Regulation, 10, 63-68.
6. Bounameaux, H. M., Hellemans, H., Verhaeghe R., & Dequeker, J. (1984). Ketanserin (r-HT-antagonist) in secondary Raynaud's phenomenon. Journal of Cardiovascular Pharmacology, 6, 975-976.
7. Coffman, J. D. (1991). Raynaud's phenomenon. An update. Hypertension. 77, 593-602.
8. Finch, M. B., Copeland, S., Passmore, A. P., & Johnston, G. D. (1986). A double-blind crossover study of nifedipine retard in patients with Raynaud's syndrome. Journal of Rheumatology, 13, (2), 331-336.
9. Franks, A. G., Sr. (1982). Topical glycerol trinitrates as adjunctive treatment in Raynaud's disease. Lancet, 1, 76.
10. Freedman, R. R. (1993). Raynaud's disease and phenomenon. In R. J. Gatchel & E. B. Blanchard (Eds.), Psychophysiological disorders (pp. 245-267). Washington, DC: American Psychological Association.
11. Freedman, R. R., Lynn, S., Ianni, P., & Hale, P. (1981). Biofeedback treatment of Raynaud's disease and phenomenon. Biofeedback and Self-Regulation, 6, 355-364.
12. Freedman, R. R., Lynn, S. S., & Ianni, P. (1982). Behavioral assessment of Raynaud's disease. In F. J. Keefe & J. A. Blumenthal (Eds.), Assessment strategies in behavioral medicine (pp. 99-132). New York: Grune & Stratton.
13. Freedman, R. R., & Ianni, P. (1983). Self-control of digital temperature: Physiological factors and transfer effects. Psychophysiology, 20, 682-688.
14. Freedman, R. R., Ianni, P., Wenig, P. (1983). Behavioral treatment of Raynaud's disease. Journal of Consulting and Clinical Psychology, 151, 539-549.
15. Freedman, R. R., Ianni, P., Wenig, P. L. (1985). Behavioral treatment of Raynaud's disease: Long-term follow up. Journal of Consulting and Clinical Psychology, 53, 136.
16. Freedman, R. R., Keegan, D., Migaly, P., Galloway, M. P. & Mayes, M. (1991). Plasma cathechodamines during behavioral treatment for Raynaud's disease. Psychosomatic Medicine, 53, 433-439.
17. Freedman, R. R., Sabharwal, S. C., Ianni, P., Desai, N., Wenig, P., & Mages, M. (1988). Nonneural beta-adrenergic vasodilating mechanism in temperature biofeedback. Psychosomatic Medicine, 50, 394-401.
18. Guglielmi, R. S., & Roberts, A. H. (1983). Of cold handed patients and warm handed therapists: A reply to Surwit and Keefe. Biofeedback and Self-Regulation, 8, 3-8.
19. Guglielmi, R. S., Roberts, A. H., & Patterson, R. (1982). Skin temperature biofeedback for Raynaud's disease: A double-blind study. Biofeedback and Self-Regulation, 7, 99-120.
20. Keefe, F. J., Surwit, R. S., & Pilon, R. N. (1980). Biofeedback, autogenie training and progressive relaxation in the treatment of Raynaud's disease. Journal of Applied Behavior Analysis, 13, 3-11.
21. Klippel, J. H. (1991). Raynaud's phenomenon, The French tricolor. Archieves of Internal Medicine, 151, 2389-2393.
22. Lewis, T. (1929). Experiments relating to the peripheral mechanism involved in spastmodic arrest of the circulation in the fingers, in variety of Raynauds disease. Heart, 15, 7-101.
23. Libo, L. M., & Arnold, G. E. (1983). Does training to criterion influence improvement? A follow-up study of EMG and thermal biofeedback. Journal of Behavioral Medicine, 6, 397-404.
24. Marcus, S., Weiner, S., Suzuki, S., & Kwan, L. (1991). Raynaud's syndrome. Postgraduate Medicine, 89(4), 171-187.
25. Mittleman, B., & Wolf, H. G. (1939). Affective States and skin temperature: experimental study of subjects with "cold hands" and Raynaud's disease. Psychosomatic Medicine, 1, 271-292.
26. Peacock, J. H. (1959). A comparative study of digital cutaneous temperature and hand blood flows in the normal hand, primary Raynaud's disease and primary acrocyanosis. Clinical Science, 18, 25-33.
27. Porter, J. M., Rivers, S. P., Anderson, C. J., & Baur,G. M. (1981). Evaluation and management of patients with Raynaud's syndrome. The American Journal of Surgery, 142, 183-189.
28. Raynaud, M. (1888). New researches on the nature and treatment of local asphyxia of the extremities (T. Barlox, Trans.) (Selected Monographs, Vol. 121). London: New Sydenham Society.
29. Rodehoffer, R. J., Rommer, J. A., Wigley, R., & Smith, C. R. (1983). Controlled double blind trail of nifedipine in the treatment cf Raynaud's phenomenon. New England Journal of Medicine, 308 880-883.
30. Sarkozi, J., Bookman, & A., Mahon, W. (1986). Nifedipine in the Treatment of Idiopathic Raynaud's syndrome. Journal of Rheumatology, 13(2), 331-36.
31. Schwartz, M. S. and Associates. (1995). Biofeedback: A practitioner's guide. New York and London: Guilford Press.
32. Sedlacek, K. (1979). Biofeedback for Raynaud's disease. Psychosomatics, 20(8), 535-541.
33. Sedlacek, K. (1984). Biofeedback treatment of primary Raynaud's. In F. J. McGuigan, W. E. Sime, & J. M. Wallace (Eds.), Stress and tension control (pp. 153-168). New York: Plenum Press.
34. Sedlacek, K. (1987, November). Biofeedback treatment of Raynaud's. Presented at first International Conference on Bio-Behavioral Self-Regulation and Health, Honolulu, Hawaii.
35. Sedlacek, K. (1989). Biofeedback treatment of primary Raynaud's disease. In J. V. Basmajian, (Ed.), Biofeedback: Principle and practice for clinicians (3rd ed.; pp. 317-321). Baltimore: William & Wilkins.
36. Smith, C. D., & McKendry, R. J. R. (1982). Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet, 2, 1299-1301.
37. Spittell, J. A., Jr. (1972). Raynaud's phenomenon and allied vasospastic conditions. In J. F. Fairbairn, J. L. Juergens, & J. A. Spittell, Jr. (Eds.), Peripheral vascular disease (pp. 387-419). Philadelphia: Saunders.
38. Surwit, R. S. (1977). Simple versus complex feedback displays in the training of digital temperature. Journal of Consulting and Clinical Psychology, 95, 146-147.
39. Surwit, R. S., & Keefe, F. J. (1983). The blind leading the blind: Problems with the "Double-blind design" in clinical biofeedback research. Biofeedback and Self-Regulation, 8, 1-2.
40. Surwit, R. S., & Jordan, J. S. (1987). Behavioral treatment of Raynaud's syndrome. In J. P. Hatch, J. G. Fisher, & J. D. Rugh (Eds.), Biofeedback. New York: Plenum Press.
41. Surwit, R. S., Pilon, R., & Fenton, C. (1978). Behavior treatment of Raynaud's disease. Journal of Behavioral Medicine, 1, 323-335.
42. Taub, E. (1977). Self-regulation of human tissue temperature. In G. Schwartz & J. Beatty (Eds.), Biofeedback: Theory and practice (pp. 265-300). New York: Academic Press.
43. Taub, E., & Emurian, C. S. (1976). Feedback-aided self-regulation of skin temperature with simple feedback locus. I. Acquistion and reversal training. Biofeedback and Self-Regulation, 1, 147-168.
44. Taub, E., & School, P. J. (1978). Some methodological considerations in thermal biofeedback training. Behavior Research Methods and Instrumentation, 10, 617-622.
45. Taub, E., & Stroebel, C. F. (1978). Biofeedback in the treatment of vasoconstrictive syndromes. Biofeedback and Self-Regulation, 3, 363-373.
46. Van de Wal, H. J., Wijn, P. F., Van Lier, H. J., & Skotnicki, S. H. (1985). Quantitative study of the effects of ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial. Microcirculation of Endothelium Lymphatics, 2, 657-85.